arrow
H

Hiroshi Iwamoto

Graduate School of Biomedical and Health Sciences
H指数:29
被引数:3,005

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIs

更正:血清总VEGF-A和VEGF-A亚型在EGFR突变型晚期非小细胞肺癌患者接受EGFR-TKIs治疗中的临床意义

2026-07-060
OAAI
Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIs

血清总VEGF-A和VEGF-A亚型在EGFR突变型晚期非小细胞肺癌经EGFR-TKIs治疗患者中的临床意义

2026-06-090
OAAI
Diversity of Factors Associated with Physical Inactivity in Patients with Asthma Based on Activity Intensity

基于活动强度的哮喘患者身体活动不足相关因素的多样性

2026-06-050
OA
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation

基线中性粒细胞与淋巴细胞比值作为非小细胞肺癌患者严重免疫检查点抑制剂肺炎风险分层标志物的两队列研究:回顾性发现与前瞻性验证

2026-06-040
OA
Uneven distribution of air trapping and its impact on physical activity in patients with asthma

哮喘患者中空气潴留分布不均及其对体力活动的影响

2026-01-011
OAAI
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004)

HMGB1在重度检查点抑制剂肺炎风险评估中的临床潜力:一项前瞻性多中心研究(CS-Lung004)

2025-07-050
OA